The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia

References

• George JN, Caen J-P, Nurden AT. Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood 1990; 75: 1383–1395
   PubMed Web of Science ®Google Scholar
• Caen JP. Glanzmann's thrombasthenia. Baillieres Clin Haematol 1989; 2: 609–625
   PubMedGoogle Scholar
• Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001; 8: 270–276
   PubMed Web of Science ®Google Scholar
• Zwaal RFA, Comfurius P, Bevers EM. Lipid-protein interactions in blood coagulation. Biochem Biophys Acta 1998; 1376: 433–453
   PubMed Web of Science ®Google Scholar
• Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maquire PB. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103: 2096–2104
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135: 603–633
   PubMed Web of Science ®Google Scholar
• Laursen B, Jacobsen SE, Taaning E, Grunnet N. Transfusion problems in patients with Glanzmann's thrombasthenia. Eur J Haematol 1992; 49: 143–144
   PubMed Web of Science ®Google Scholar
• Poon M-C, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann's thrombasthenia. Blood 1999; 94: 3951–3953
   PubMed Web of Science ®Google Scholar
• Poon MC. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Vasc Health Risk Manag 2007; 3: 655–664
   PubMedGoogle Scholar
• Di Minno G, Coppola A, Di Minno MND, Poon M-C. Glanzmann's thrombasthenia (defective platelet integrin αIIb-β3): Proposals for management between evidence and open issues. Thromb Haemost 2009; 102: 1157–1164
   PubMed Web of Science ®Google Scholar
• Valentino LA. Use of rFVIIa in 4 children with Glanzmann thrombasthenia. J Pediatr Hematol Oncol 2004; 28: 653–658
   Web of Science ®Google Scholar
• Dargaud Y, Bordet JC, Trzeciak MC, Vinciguerra C, Negrier C. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor VIIa during a surgical procedure: Observations on the monitoring and the mechanism of action of this drug. Haematologica 2006; 91(6 Suppl)ECR20
   PubMedGoogle Scholar
• Eduran E, Aksoy A, Zaman D. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy. Blood Coagul Fibrinolysis 2009; 20: 215–217
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997; 90: 2515–2521
   PubMed Web of Science ®Google Scholar
• Coppola A, Di Minno G. Desmopressin (DDAVP) in inherited disorders of platelet function. Haemophilia 2008; 14(Suppl. 1)31–39
   PubMed Web of Science ®Google Scholar
• Lombardo VT, Sottliota G. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanxmann's thrombasthenia. Clin Appl Thromb Hemost 2006; 12: 115–116
   PubMed Web of Science ®Google Scholar
• Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Bequin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4–15
   PubMed Web of Science ®Google Scholar
• Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Kingler A, Kilma G, Martinowitz U, Fries D. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007; 5: 1019–1025
   PubMed Web of Science ®Google Scholar
• Johansson PI, Svendsen MS, Salado J, Bochsen L, Kristensen AT. Investigation of the thrombin-generating capacity, evaluated by thrombogram, and clot formation evaluated by thromboelastography of platelets stored in the blood bank for up to 7 days. Vox Sanguinis 2008; 94: 113–118
   PubMed Web of Science ®Google Scholar
• Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thromboelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100: 792–797
   PubMed Web of Science ®Google Scholar
• Chen A, Teruya J. Global hemostasis testing thromboelastography: Old technology, new applications. Clin Lab Med 2009; 29: 391–407
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sorensen B. Thromboelastographic whole blood clot formation after ex vivo addition of plasma substitutes: Improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anesth 2005; 94: 324–329
   PubMed Web of Science ®Google Scholar
• Fries D, Innerhofer P, Reif C, Streif W, Klinger A, Schobersberger W, Velik-Salchner C, Friesennecker B. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: An in vitro model. Anesth Analg 2006; 102: 347–351
   PubMed Web of Science ®Google Scholar
• Haas T, Fries D, Velik-Salchner C, Reif C, Klinger A, Innerhofer P. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008; 106: 1360–1365
   PubMed Web of Science ®Google Scholar
• Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model. Brit J Anaesth 2009; 102: 793–799
   PubMed Web of Science ®Google Scholar
• Misgav M, Shenkman B, Budnik I, Einav Y, Martinowitz U. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia. Anesth Analg 2011; 112: 1034–1405
   PubMed Web of Science ®Google Scholar
• Male C, Koren D, Eichelberger B, Kaufmann K, Panzer S. Monitoring survival and function of transfused platelets in Glanzmann thrombasthenia by flow cytometry and thrombelastography. Vax Sang 2006; 91: 174–177
   PubMed Web of Science ®Google Scholar
• Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (haemocomplettan P). Anesth Analg 2008; 106: 732–738
   PubMed Web of Science ®Google Scholar
• Walker JB, Bajzar L. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: The role and requirement of plasmin inhibitors. J Thromb Haemost 2007; 5: 1257–1264
   PubMed Web of Science ®Google Scholar
• Muszbek L, Bagoly Z, Bereczky Z, Katona E. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. Cardiovasc Hematol Agents Med Chem 2008; 6: 190–205
   PubMedGoogle Scholar
• Schramko AA, Kuitunen AH, Suojaranta-Yinen RT, Niemi TT. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin-haemodilution. Acta Anaesth Scand 2009; 53: 731–735
   PubMed Web of Science ®Google Scholar
• Theusinger OM, Bauling W, Asmis LM, Seifert B, Spahn DR. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 2010; 104: 385–391
   PubMed Web of Science ®Google Scholar
• Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: Implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010; 104: 318–325
   PubMed Web of Science ®Google Scholar
• Vucellic D, Milijc P, Antonijevic N, Ilicevic M. The role of rotational thromboelastometry in real time assessment of haemostasis in surgical settings. Srp Arch Celok Lek 2010; 138(Suppl. 1)43–49
   Google Scholar
• Lison S, Spannag M, Heind B. Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery. Blood Coagul Fibrinolysis 2009; 20: 371–373
   PubMed Web of Science ®Google Scholar
• Lang T, Bauters A, Braun SL, Pötzsch B, von Pape KW, Kolde HJ, Lakner M. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinol 2005; 16: 301–310
   PubMed Web of Science ®Google Scholar